GLP-1 Market
LLY $1306.69 ▲ +2.8% NVO $39.43 ▲ +0.9% PFE $30.42 ▲ +1.9% VKTX $25.83 ▼ -2.1% KLRA $13.27 ▲ +2.7% GPCR $21.93 ▼ -0.4% RHHBY $59.62 ▲ +0.9%
Market data delayed up to 20 min · Source: Twelve Data

Empowering you to have better conversations with your doctor.

Subscribe
About this data Sourced primarily from ClinicalTrials.gov — a listing isn't proof of safety or FDA approval.

Pipeline and clinical trial information here comes primarily from ClinicalTrials.gov. A listing on ClinicalTrials.gov means a study has been registered — not that a treatment is proven safe, effective, or FDA-approved. Investigational treatments may never be approved. Who can join a trial is decided only by that trial's own study team.

Not yet reported

Sus Scrofa Adrenal Gland

Company
Johns Hopkins University
Mechanism
Mechanism not yet reported
Route
Route not yet reported
Recruiting trials
5 recruiting

Efficacy results: Not yet reported

Find a Clinical Trial Near Me

5 recruiting studies currently listed on ClinicalTrials.gov.

Data source: ClinicalTrials.gov · trial data as of Oct 23, 2026

Find a Clinical Trial Near Me

See recruiting studies for Sus Scrofa Adrenal Gland and check eligibility with the study team.

Select conditions
Match
Treatment type

"Added to GLP-1" means the investigational treatment is being studied on top of an existing GLP-1-based therapy.

Your ZIP code is only used to calculate distance to trial sites — it isn't stored.

Trial details
  • Recruiting NCT NCT02000089

    The Cancer of the Pancreas Screening-5 CAPS5)Study

    Not yet reported Johns Hopkins University 9000 participants Est. completion 2029-06 9 sites
    Other conditions: Pancreas Cancer, Peutz-Jeghers Syndrome (PJS), Gene Mutation, Germline Mutation Carrier, Lynch Syndrome
    View official trial listing →
  • Recruiting NCT NCT02823665

    The Effects of Bariatric Surgeries on Glucose Metabolism

    Not yet reported The University of Texas Health Science Center at San Antonio 200 participants Est. completion 2027-08 2 sites Stand-alone
    Other conditions: Post Bariatric Surgery, Gastric Bypass, Sleeve Gastrectomy, Hypoglycemia After Gastric Bypass
    View official trial listing →
  • Recruiting NCT NCT03099850

    Prospective Evaluation of Chronic Pancreatitis for Epidemiologic and Translational Studies

    M.D. Anderson Cancer Center 2345 participants Est. completion 2030-06-30 1 site
    Other conditions: Pancreatitis
    View official trial listing →
  • Recruiting NCT NCT05235867

    Secretin in Refeeding

    University of California, Los Angeles 10 participants Est. completion 2027-12-31 1 site
    Other conditions: Anorexia in Adolescence
    View official trial listing →
  • Recruiting NCT NCT07285863

    A Study Of Effect Of Secretin For In Injection (Chirostim) On Pancreatic Fluid Composition In Healthy Subjects

    Not yet reported Mayo Clinic 24 participants Est. completion 2028-03 1 site Stand-alone
    Other conditions: Exocrine Pancreatic Insufficiency, Chronic Pancreatitis
    View official trial listing →
  • Terminated NCT NCT00036231

    Synthetic Human Secretin in Children With Autism and Gastrointestinal Dysfunction

    Not yet reported Repligen Corporation
    Other conditions: Autism
    View official trial listing →
  • Completed NCT NCT00036244

    Synthetic Human Secretin in Children With Autism

    Not yet reported Repligen Corporation Est. completion 2004-01 15 sites
    Other conditions: Autism
    View official trial listing →
  • Completed NCT NCT00065962

    Secretin for the Treatment of Autism

    Not yet reported Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) 85 participants Est. completion 2000-05 2 sites
    Other conditions: Autism
    View official trial listing →
  • Completed NCT NCT00216294

    Safety Study of the Drug RG1068 in Patients With Obsessive Compulsive Disorder

    Not yet reported Indiana University 12 participants Est. completion 2006-04 1 site Stand-alone
    Other conditions: Obsessive Compulsive Disorder (OCD)
    View official trial listing →
  • Completed NCT NCT00235274

    Effects of RG1068 (Secretin) on Information Processing in Schizophrenia

    Not yet reported Indiana University 30 participants Est. completion 2006-08 1 site
    Other conditions: Schizophrenia
    View official trial listing →
  • Status unknown NCT NCT00259532

    Three New Methods for Diagnosing Pancreas Cancer

    Not yet reported University of Copenhagen 80 participants Est. completion 2009-01 1 site
    Other conditions: Pancreas Cancer
    View official trial listing →
  • Completed NCT NCT00438906

    Cancer of the Pancreas Screening Study (CAPS 3)

    Johns Hopkins University 200 participants Est. completion 2009-12 1 site
    Other conditions: Pancreatic Neoplasm, Peutz-Jeghers Syndrome
    View official trial listing →
  • Terminated NCT NCT00587132

    Secretin (ChiRhoStim) Pancreas Perfusion for Pancreatic Adenocarcinoma

    Not yet reported, Not yet reported Mayo Clinic 4 participants Est. completion 2012-02 1 site Stand-alone
    Other conditions: Pancreatic Cancer
    View official trial listing →
  • Terminated NCT NCT00620919

    Secretin Enhanced Multidetector CT Pancreatography for Evaluation of Known or Suspected Chronic Pancreatitis

    Not yet reported Massachusetts General Hospital Est. completion 2008-12 1 site Stand-alone
    Other conditions: Chronic Pancreatitis
    View official trial listing →
  • Terminated NCT NCT00621283

    Secretin Enhanced MRCP for Evaluation of Pancreatic Duct in Pediatric Population

    Not yet reported Massachusetts General Hospital Est. completion 2008-12 1 site Stand-alone
    Other conditions: Acute Recurrent Pancreatitis, Chronic Pancreatitis
    View official trial listing →
  • Terminated NCT NCT00621556

    Secretin Enhanced MRCP for Evaluation of the Known or Suspected Intraductal Papillary Mucinous Neoplasms of the Pancreas

    Not yet reported Massachusetts General Hospital 2 participants Est. completion 2008-12 1 site Stand-alone
    Other conditions: Intraductal Papillary Mucinous Neoplasms
    View official trial listing →
  • Completed NCT NCT00651053

    Endoscopic Ultrasound Compared With Pancreatic Function Testing for Diagnosis of Chronic Pancreatitis

    Not yet reported The Cleveland Clinic 70 participants Est. completion 2007-12 1 site
    Other conditions: Chronic Pancreatitis
    View official trial listing →
  • Completed NCT NCT00660335

    Safety and Efficacy of Synthetic Human Secretin-Enhanced MRCP in Subjects With Abnormalities of the Pancreas

    Not yet reported Repligen Corporation 258 participants Est. completion 2009-10 Stand-alone
    Other conditions: Pancreatitis
    View official trial listing →
  • Completed NCT NCT01087801

    A Study of Synthetic Human Secretin (ChiRhoStim®) Administered Intravenously to Stimulate Exocrine Pancreas Fluid Secretion for Collection Via Endoscope and Laboratory Analysis of DNA Markers

    Not yet reported ChiRhoClin, Inc. 64 participants Est. completion 2009-12 1 site
    Other conditions: Pancreatic Disease
    View official trial listing →
  • Withdrawn NCT NCT01094535

    Secretin-enhanced Magnetic Resonance Cholangiopancreatography (S-MRCP) and Pancreatic Function Following Surgery

    Not yet reported Columbia University Est. completion 2012-09 1 site Stand-alone
    Other conditions: Pancreatic Cancer
    View official trial listing →
  • Completed NCT NCT01094561

    Secretin-Stimulated Magnetic Resonance Cholangiopancreatography (S-MRCP) in Pancreatic Patients

    Not yet reported Elizabeth Hecht 23 participants Est. completion 2015-03 1 site Stand-alone
    Other conditions: Pancreatic Cancer
    View official trial listing →
  • Withdrawn NCT NCT01094600

    Comparison of Secretin-enhanced Magnetic Resonance Cholangiopancreatography (S-MRCP) to Endoscopic Pancreatic Function Test (ePFT) in Diagnosing Pancreatic Exocrine Insufficiency

    Not yet reported Columbia University Est. completion 2012-06 Stand-alone
    Other conditions: Pancreatic Cancer
    View official trial listing →
  • Withdrawn NCT NCT01094626

    Secretin-enhanced Magnetic Resonance Imaging (S-MRI) for Pancreatic Cancer Detection

    Not yet reported Elizabeth Hecht Est. completion 2013-03 Stand-alone
    Other conditions: Pancreatic Cancer, Intraductal Papillary Mucinous Neoplasm
    View official trial listing →
  • Completed NCT NCT01134848

    A Study of Serial Magnetic Resonance Cholangiopancreatography (MRCP) Following Morphine-neostigmine and Secretin Provocation in Healthy Volunteers

    Not yet reported University of Nottingham 10 participants Est. completion 2010-02 1 site
    Other conditions: Sphincter of Oddi Dysfunction
    View official trial listing →
  • Completed NCT NCT01184573

    Novel Breath Test to Detect Early Stage Chronic Pancreatitis

    Metabolic Solutions Inc. 50 participants Est. completion 2012-09 1 site
    Other conditions: Chronic Pancreatitis
    View official trial listing →
  • Completed NCT NCT01259544

    BreathID® Test: A Non-invasive Modality to Detect Pancreatic Exocrine Insufficiency

    Not yet reported Meridian Bioscience, Inc. 33 participants Est. completion 2009-03 1 site
    Other conditions: Chronic Pancreatitis, Healthy Volunteers
    View official trial listing →
  • Completed NCT NCT01265875

    Secretin Infusion for Pain Due to Chronic Pancreatitis

    Not yet reported, Not yet reported ChiRhoClin, Inc. 12 participants Est. completion 2012-04 1 site
    Other conditions: Chronic Pancreatitis
    View official trial listing →
  • Withdrawn NCT NCT01371240

    Secretin-Assisted Computed Tomography Scan and Magnetic Resonance Imaging in Improving Pancreatic Tumor Conspicuity

    Not yet reported University Hospitals Cleveland Medical Center Est. completion 2012-06 1 site
    Other conditions: Pancreas Cancer
    View official trial listing →
  • Completed NCT NCT01452217

    Non-invasive MRI to Quantify the Effect of Secretin on Pancreatic Blood Flow and Perfusion in Healthy Volunteers

    Not yet reported University of Nottingham 12 participants Est. completion 2011-10 1 site Stand-alone
    Other conditions: Chronic Pancreatitis
    View official trial listing →
  • Withdrawn NCT NCT01845467

    Efficacy of Secretin MRCP in the Diagnosis and Follow up of Auto Immune Pancreatitis

    Johns Hopkins University Est. completion 2018-12 1 site
    Other conditions: Cellular Diagnosis, Pancreatic Cancer, Autoimmune Pancreatitis
    View official trial listing →
  • Completed NCT NCT01997476

    EUS Ductal Evaluation in One Endoscopic Session for the Diagnosis of Exocrine Pancreas Disease

    Not yet reported Indiana University 166 participants Est. completion 2018-02-06 1 site
    Other conditions: Pancreatic Disease
    View official trial listing →
  • Completed NCT NCT02160808

    Secretin Infusion to Prevent Pancreatic Leaks Following Pancreatic Resection

    Not yet reported, Not yet reported Dartmouth-Hitchcock Medical Center 170 participants Est. completion 2019-09-21 1 site
    Other conditions: Injury of Body of Pancreas
    View official trial listing →
  • Status unknown NCT NCT02458118

    Pancreatic Perfusion Using Secretin and MRI

    Not yet reported, Not yet reported University of Nottingham 15 participants Est. completion 2016-06 1 site Stand-alone
    Other conditions: Chronic Pancreatitis
    View official trial listing →
  • Completed NCT NCT02869893

    MRCP: A Reliable, Non Invasive Method for Staging Chronic Pancreatitis in Pediatrics

    Not yet reported Children's Hospital Medical Center, Cincinnati 57 participants Est. completion 2017-04-06 1 site
    Other conditions: Healthy Volunteers
    View official trial listing →
  • Completed NCT NCT03263481

    Intraductal Secretin Stimulation Test: What Is the Proper Collection Time?

    Not yet reported Indiana University 8 participants Est. completion 2023-09-01 1 site Stand-alone
    Other conditions: Cholangiopancreatography, Endoscopic Retrograde
    View official trial listing →
  • Completed NCT NCT03290846

    Secretin Activates Human Brown Fat and Induces Satiation.

    Not yet reported, Not yet reported Turku University Hospital 23 participants Est. completion 2019-11-30 1 site Stand-alone
    Other conditions: Obesity
    View official trial listing →
  • Completed NCT NCT03404661

    Optical and Biochemical Biomarkers in Early Pancreatic Cancer

    Mayo Clinic 346 participants Est. completion 2022-03-10 1 site
    Other conditions: Pancreatic Cancer
    View official trial listing →
  • Completed NCT NCT03617861

    Effect of Secretin in Functional Dyspepsia and Healthy Subjects

    Not yet reported, Not yet reported Mayo Clinic 20 participants Est. completion 2019-08-01 1 site Stand-alone
    Other conditions: Dyspepsia, Healthy
    View official trial listing →
  • Status unknown NCT NCT03686618

    Secretin for Acute Pancreatitis

    Not yet reported ChiRhoClin, Inc. 40 participants Est. completion 2019-11-01 1 site
    Other conditions: Pancreatitis, Acute
    View official trial listing →
  • Completed NCT NCT03770910

    The Effect of GIP(3-30)NH2

    Not yet reported University Hospital, Gentofte, Copenhagen 8 participants Est. completion 2019-12-01 2 sites
    Other conditions: Endocrine - Other
    View official trial listing →
  • Completed NCT NCT04207060

    Trial of Indomethacin in Chronic Pancreatitis

    Not yet reported, Not yet reported Mayo Clinic 27 participants Est. completion 2023-04-24 2 sites Stand-alone
    Other conditions: Chronic Pancreatitis
    View official trial listing →
  • Terminated NCT NCT04231279

    Recurrent Abdominal Pain and Exocrine Pancreatic Insufficiency

    Not yet reported Orlando Health, Inc. 27 participants Est. completion 2023-06-15 1 site Stand-alone
    Other conditions: Abdominal Pain, Irritable Bowel Syndrome
    View official trial listing →
  • Completed NCT NCT04613700

    The Role of Secretin on the Energy Homeostasis

    Not yet reported Steno Diabetes Center Copenhagen 25 participants Est. completion 2020-09-29 1 site
    Other conditions: Obesity, Metabolic Disease, Diabetes, Adiposity
    View official trial listing →
  • Completed NCT NCT04615702

    Evidence Based Management of Acute Biliary Pancreatitis

    Zagazig University 30 participants Est. completion 2019-05-15 1 site
    Other conditions: Acute Pancreatitis
    View official trial listing →
  • Enrolling by invitation NCT NCT04793633

    Evaluating LINFU™: A Noninvasive Method for Collecting Pancreatic Cells for the Early Detection of Pancreatic Cancer

    Adenocyte, LLC 500 participants Est. completion 2030-12-30 1 site
    Other conditions: Pancreatic Ductal Adenocarcinoma
    View official trial listing →
  • Completed NCT NCT05161013

    A Proof-of-Concept Study Evaluating LINFU™

    Not yet reported Adenocyte, LLC 12 participants Est. completion 2023-10-30 1 site Stand-alone
    Other conditions: Pancreas Adenocarcinoma, Dysplasia
    View official trial listing →
  • Enrolling by invitation NCT NCT05659147

    Imaging Biomarkers of Pancreatic Function and Disease

    Not yet reported Children's Hospital Medical Center, Cincinnati 195 participants Est. completion 2027-12 1 site Stand-alone
    Other conditions: Pancreatitis, Diabetes Mellitus
    View official trial listing →
  • Status unknown NCT NCT05914077

    Aspiration of Duodenopancreatic Juice After Secretin Stimulation vs Endoscopic Aspiration for Molecular Analysis of Intraductal Papillary Mucinous Intraductal Neoplasia.

    Not yet reported Fundacion Clinic per a la Recerca Biomédica 140 participants Est. completion 2025-01 1 site Stand-alone
    Other conditions: Intraductal Papillary Mucinous Neoplasm of Pancreas
    View official trial listing →
  • Not yet recruiting NCT NCT06276738

    The LINFU® U.S. Registry in Patients With Clinical Signs and/or Symptoms of Disease

    Adenocyte, LLC 1000 participants Est. completion 2034-05-01
    Other conditions: Pancreatic Cancer, Jaundice, Abdominal Neoplasm
    View official trial listing →
  • Enrolling by invitation NCT NCT06276764

    The LINFU® U.S. Registry in Patients With IPMN (Intraductal Papillary Mucinous Neoplasm of the Pancreas)

    Adenocyte, LLC 500 participants Est. completion 2034-12-01 1 site
    Other conditions: IPMN, Pancreatic, Pancreas Cancer, Pancreatic Cyst
    View official trial listing →
  • Not yet recruiting NCT NCT06276803

    The LINFU® U.S. Registry for the in the General Population Without Risk Factors

    Adenocyte, LLC 500 participants Est. completion 2034-12-15
    Other conditions: Pancreatic Cancer, Pancreatic Ductal Adenocarcinoma, Pancreatic Dysplasia
    View official trial listing →
  • Not yet recruiting NCT NCT06807112

    The Influence of Secretin Stimulated Pancreatic Secretion on ctDNA Expression in Patients With Pancreatic Ductal Adenocarcinoma: The Role of Biomarkers in Determining the Prognosis of Pancreatic Ductal Adenocarcinoma

    Charles University, Czech Republic 39 participants Est. completion 2027-02-01 1 site
    Other conditions: Pancreatic Adenocarcinoma, Pancreatic Cancer
    View official trial listing →
  • Enrolling by invitation NCT NCT07651748

    Secretin in Ex-situ Liver Perfusion

    Not yet reported, Not yet reported Erasmus Medical Center 20 participants Est. completion 2026-10 1 site Stand-alone
    Other conditions: Liver Transplantation
    View official trial listing →
Efficacy history

Not yet reported.

Safety

Not yet reported.

Sources

Also known as: Sus Scrofa Adrenal Gland, Secretin Cycle II Drops 2164, Secretin Cycle I Drops 2163, Secretin, ChiRhoStim

Related On The Pen coverage

No related coverage yet.

This drug may be investigational and not yet approved for any use. Whether someone can join a clinical trial is determined only by that trial's own study team — On The Pen does not determine eligibility. Information here can change; always confirm current details on the official ClinicalTrials.gov listing or with the sponsor.